Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study "ANUS1014"

Terminated

Phase 4 Results

Summary of Purpose

Primary Objective: To determine the effects of a diabetes specific enteral formula compared to a standard formula supplemented with protein (isocaloric and isonitrogenous) on the mean blood glucose and glycemic variability in a homogenous group of critically ill patients in a neurological ICU. Blood glucose will... Trial Stopped: Unlikely to show statistical significance and slow recruitment.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 October 2012.

1 Nov 2011 24 Oct 2011 1 Jun 2012 1 Jun 2012 1 Oct 2012 22 Jun 2012
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Paul e Marik, MD

  • Michael Gonzales, MD

    757-446-8910